Search results
Sun Pharma’s Phase I GL0034 study shows weight loss efficacy and lipid reduction
Clinical Trials Arena via Yahoo Finance· 22 hours agoDanish company Novo Nordisk recently reported DKr61bn ($8.7bn) in sales from...loss, Zealand Pharma...
ASCO24: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Pharmaceutical Technology via Yahoo Finance· 2 hours agoIn March, Rakuten raised $119m in a Series E financing round to develop its Alluminox drug discovery...
Pharmaceutical IT leaders: Speed drug discovery and development with data lakes
CIO· 3 days agoA unified data foundation is critical for pharmaceutical organizations to optimize drug development....
Health Care Roundup: Market Talk
The Wall Street Journal· 3 hours ago0748 GMT – AstraZeneca cancer-drug Imfinzi positive results from bladder-cancer trial outweigh the negative outcome of the treatment’s lung-cancer trial,...
Alnylam hits ‘home run’ in clinical trial, shares rise 35% - Boston Business Journal
The Business Journals· 20 hours agoShares of Alnylam Pharmaceuticals Inc. shot up Monday after the company reported a successful...
Chapel Hill pharma fights back against fentanyl crisis - Triangle Business Journal
The Business Journals· 1 day agoA pharmaceutical company in Chapel Hill is advancing its efforts to address the fentanyl crisis....
Pharma stock jumps after receiving inspection report from USFDA for its manufacturing facility
Investing.com· 1 day agoThe shares of this pharmaceutical company gained up to 2 percent after the company received the...
ASCO24: Novartis’ Scemblix outperforms standard of care in CML
Pharmaceutical Technology via Yahoo Finance· 2 hours agoOncology Review (RTOR) programme. The company reported $136m in sales for Scemblix in Q1 this year,...
2 Beaten-Down Growth Stocks to Buy Without Hesitation in the 2024 Bull Market
Motley Fool via Yahoo Finance· 1 day agoPfizer also used its COVID-19 funds to fuel aggressive research and development efforts. In 2023,...
Alnylam’s stock surges as heart drug vies with a Pfizer blockbuster
Market Watch· 1 day agojumped nearly 40% premarket on Monday after the company released results of a late-stage trial for a...